Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Agios Pharmaceuticals Q2 EPS $(1.93) Misses $(1.77) Estimate, Sales $12.455M Beat $9.537M Estimate

Author: Benzinga Newsdesk | July 31, 2025 06:32am
Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.93) per share which missed the analyst consensus estimate of $(1.77) by 8.73 percent. This is a 14.2 percent decrease over losses of $(1.69) per share from the same period last year. The company reported quarterly sales of $12.455 million which beat the analyst consensus estimate of $9.537 million by 30.59 percent. This is a 44.57 percent increase over sales of $8.615 million the same period last year.

Posted In: AGIO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist